Key result
The crystal structure of Senecavirus A 3C protease at 1.9 Å resolution revealed a unique positively charged protrusion around S' subsites and a wide tolerance for P4 residue volume.
Why the study?
Development of antiviral drugs and virus-like particle vaccines is challenged by limited knowledge of how subsite structure determines the picornavirus 3C protease cleavage pattern.
The structural determination of SVA 3C protease provides insights into its cleavage pattern, which may aid in the development of antiviral drugs and virus-like particle vaccines.
Holds no immediate clinical application; leaves open a structural foundation for future antiviral drug and vaccine development targeting the.
Picornaviridae is a group of RNA viruses that harm both humans and livestock. 3C pro is an essential enzyme for picornavirus maturation, which makes it a promising target for antiviral drug development and a critical component for virus-like particle (VLP) production. However, the current challenge in the development of antiviral drugs and VLP vaccines includes the limited knowledge of how subsite structure determines the 3C pro cleavage pattern.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2022) studied Senecavirus A infection. Crystal structure analysis of SVA 3C protease was evaluated on Crystal structure resolution and cleavage specificity. The crystal structure of Senecavirus A 3C protease at 1.9 Å resolution revealed a unique positively charged protrusion around S' subsites and a wide tolerance for P4 residue volume.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: